Lucid Diagnostics, Inc. (LUCD)
Lucid Diagnostics Market Cap : 77.86M for Nov. 18, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 18, 2026 | 77.86M |
| November 17, 2026 | 76.20M |
| November 16, 2026 | 75.97M |
| November 13, 2026 | 85.77M |
| November 12, 2026 | 79.50M |
| November 11, 2026 | 72.84M |
| November 10, 2026 | 76.39M |
| November 09, 2026 | 79.64M |
| November 06, 2026 | 75.92M |
| November 05, 2026 | 74.41M |
| November 04, 2026 | 84.91M |
| November 03, 2026 | 78.02M |
| November 02, 2026 | 77.50M |
| October 30, 2026 | 77.22M |
| October 29, 2026 | 82.46M |
| October 28, 2026 | 78.52M |
| October 27, 2026 | 83.57M |
| October 26, 2026 | 95.51M |
| October 23, 2026 | 78.40M |
| October 22, 2026 | 62.51M |
| October 21, 2026 | 63.60M |
| October 20, 2026 | 67.13M |
| October 19, 2026 | 71.99M |
| October 16, 2026 | 91.18M |
| October 15, 2026 | 99.21M |
| Date | Value |
|---|---|
| October 14, 2026 | 103.60M |
| October 13, 2026 | 115.60M |
| October 12, 2026 | 113.96M |
| October 09, 2026 | 121.70M |
| October 08, 2026 | 124.01M |
| October 07, 2026 | 118.94M |
| October 06, 2026 | 114.45M |
| October 05, 2026 | 113.18M |
| October 02, 2026 | 119.66M |
| October 01, 2026 | 121.09M |
| September 30, 2026 | 143.26M |
| September 29, 2026 | 154.32M |
| September 28, 2026 | 153.69M |
| September 25, 2026 | 157.57M |
| September 24, 2026 | 159.85M |
| September 23, 2026 | 160.03M |
| September 22, 2026 | 170.27M |
| September 21, 2026 | 161.21M |
| September 18, 2026 | 149.88M |
| September 17, 2026 | 148.87M |
| September 16, 2026 | 159.55M |
| September 15, 2026 | 151.38M |
| September 14, 2026 | 149.29M |
| September 11, 2026 | 149.34M |
| September 10, 2026 | 153.39M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| PAVmed, Inc. | 9.168M |
| Stereotaxis, Inc. | 95.39M |
| Glaukos Corp. | 13.79B |
| CVRx, Inc. | 17.21M |
| Hyperfine, Inc. | 57.87M |
Market Cap Related Metrics
| PS Ratio | 12.10 |
| Price to Book Value | 13.13 |
| Price | 0.4077 |
| Earnings Yield | -100.1% |